|
Symbol Name ID |
Mocs2
molybdenum cofactor synthesis 2 MGI:1336894 |
| Darker colors indicate more annotations |
| Human Phenotypes | Hypouricemia |
Molybdenum cofactor deficiency |
Increased urinary hypoxanthine level |
Decreased urinary urate |
Increased urinary taurine |
Increased urinary sulfite level |
Xanthinuria |
| Disease(s) Associated with MOCS2 | |||||||
| molybdenum cofactor deficiency type B |
| Mouse Phenotypes | increased circulating creatinine level |
cystinuria |
abnormal blood homeostasis |
decreased blood uric acid level |
increased fasting circulating glucose level |
decreased circulating sodium level |
increased urine hypoxanthine level |
increased urine protein level |
hemoglobinuria |
decreased urine uric acid level |
increased urine xanthine level |
erythrocyturia |
abnormal enzyme/coenzyme activity |
|
| Availability | Mouse Genotype | |||||||||||||
| Mocs2tm1(KOMP)Vlcg/Mocs2tm1(KOMP)Vlcg | ||||||||||||||
| Mocs2tm1b(EUCOMM)Wtsi/Mocs2+ | ||||||||||||||
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 04/23/2024 MGI 6.23 |
|
|
|
||
Analysis Tools